Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis

The epidermal growth factor pathway has been implicated in various tumors, including human papillomavirus (HPV) lesions such as recurrent respiratory papillomatosis (RRP). Due to the presence of epidermal growth factor receptors in RRP, epidermal growth factor receptor (EGFR) inhibitors have been ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Moldan, Matthew M., Bostrom, Bruce C, Tibesar, Robert J, Lander, Timothy A., Sidman, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999927/
https://www.ncbi.nlm.nih.gov/pubmed/24795806
http://dx.doi.org/10.12688/f1000research.2-202.v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999927/
https://www.ncbi.nlm.nih.gov/pubmed/24795806
http://dx.doi.org/10.12688/f1000research.2-202.v1

Ejemplares similares